Use of the drug Prostatex plus in patients with chronic abacterial prostatitis and BPH
- Authors: Neymark A.I.1, Nozdrachev N.A.1, Kulchavenya E.V.2, Kholtobin D.P.1, Davydov A.V.1, Neymark A.B.1, Kovaleva Y.S.1, Yakovlev A.V.1
-
Affiliations:
- Altai State Medical University of the Ministry of Health of Russia
- FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia
- Issue: No 2 (2024)
- Pages: 41-46
- Section: Original Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/633552
- DOI: https://doi.org/10.18565/urology.2024.2.41-46
- ID: 633552
Cite item
Abstract
Aim. To evaluate the efficiency of therapy with Prostatex plus rectal suppositories in the treatment of patients with chronic abacterial prostatitis and benign prostatic hyperplasia (BPH).
Materials and methods. A total of 50 men with chronic abacterial prostatitis of category III A, occurring in combination with BPH, were included in the study. All patients received Prostatex plus (rectal suppositories) 1 suppository 1 time per day. The duration of treatment was 20 days. After taking the drug, patients were followed-up for 40 days. There were three follow-up visits during the study period (days 1, 20 and 60).
Results. The study proved that the use of Prostatex plus rectal suppositories has a positive effect on urinary parameters, subjective and objective symptoms of chronic abacterial prostatitis and BPH, which allowed to recommend it for this group of patients, according to the following scheme: 1 suppository 1 time per day for 20 days.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
A. I. Neymark
Altai State Medical University of the Ministry of Health of Russia
Author for correspondence.
Email: urologagmu@mail.ru
Ph.D., MD, professor, Head of the Department of Urology and Andrology with a course of Specialized Surgery
Russian Federation, BarnaulN. A. Nozdrachev
Altai State Medical University of the Ministry of Health of Russia
Email: nozdrachevuro@mail.ru
Ph.D., associate professor at the Department of Urology and Andrology with a course of Specialized Surgery
Russian Federation, BarnaulE. V. Kulchavenya
FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia
Email: urotub@yandex.ru
Ph.D., MD, professor, professor at the Department of Phthisiopulmonology
Russian Federation, NovosibirskD. P. Kholtobin
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
Ph.D., MD, professor, professor at the Department of Urology and Andrology with a course of Specialized Surgery
Russian Federation, BarnaulA. V. Davydov
Altai State Medical University of the Ministry of Health of Russia
Email: andre1763@mail.ru
Ph.D., MD, associate professor, professor at the Department of Urology and Andrology with a course of Specialized Surgery
Russian Federation, BarnaulA. B. Neymark
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
student
Russian Federation, BarnaulYu. S. Kovaleva
Altai State Medical University of the Ministry of Health of Russia
Email: k-derm@asmu.ru
Ph.D., MD, associate professor, Head of the Department of Dermatology and Venerology, Cosmetology and Immunology
Russian Federation, BarnaulA. V. Yakovlev
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
Ph.D., associate professor, assistant at the Department of Urology and Andrology with a course of Specialized Surgery
Russian Federation, BarnaulReferences
- Lopatkin N.A. (ed.). Benign prostatic hyperplasia.-M., 1999; 216. Russian (Лопаткин Н.А.(ред.). Доброкачественная гиперплазия предстательной железы.-М., 1999; 216).
- Tkachuk V.N., Al-Shukri S.H., Lukyanov A.E. Medical treatment of patients with benign prostatic hyperplasia. St. Petersburg, 2000; 104. Russian (Ткачук В.Н., Аль-Шукри С.Х., Лукьянов А.Э. Медикаментозное лечение больных доброкачественной гиперплазией предстательной железы. СПб., 2000; 104).
- Tkachuk V.N., Al-Shukri S.H., Lotzan-Medvedev A.K. Evaluation of the effectiveness of vitaprost in patients with chronic abacterial prostatitis. Urology. 2006;2:71–75. Russian (Ткачук В.Н., Аль-Шукри С.Х., Лотцан-Медведев А.К. Оценка эффективности витапроста у больных хроническим абактериальным простатитом. Урология. 2006;2:71–75).
- Al-Shukri S.H., Gorbachev A.G., Tkachuk V.N. Our experience in the use of prostatilene in urology. Urology. 2003;6:32–36. Russian (Аль-Шукри С.Х., Горбачев А.Г., Ткачук В.Н. Наш опыт применения простатилена в урологии. Урология. 2003;6:32–36).
- Al-Shukri S.H., Gorbachev A.G., Borovets S.Yu., etc. Treatment of patients with prostate adenoma with prostatilen. Urology. 2006;6:22–26. Russian (Аль-Шукри С.Х., Горбачев А.Г., Боровец С.Ю. и др. Лечение больных аденомой предстательной железы простатиленом. Урология. 2006;6:22–26).
- Kamalov A.A., Efremov E.A., Dorofeev S.D. and others. Vitaprost-forte in the treatment of patients with prostate adenoma. Urology. 2007;3:39–47. Russian (Камалов А.А., Ефремов Е.А., Дорофеев С.Д. и др. Витапрост-форте в лечении больных с аденомой предстательной железы. Урология. 2007;3:39–47).
- Pushkar D.Yu., Rasner P.I. Symptoms of the lower urinary tract and benign prostatic hyperplasia. Urology 2006;3(adj.):4–18. Russian (Пушкарь Д.Ю., Раснер П.И. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы. Урология 2006;3(прил.):4–18).
- Emberton M., Fitzpatrick J.M., Garcia-Losa M., Qizilbash N., Djavan B. Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials. BJU Int. 2008;102:981–986.
- Management of Non-neurogenic Male LUTS. European Association of Urology Guidelines. http://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/
- Management of Benign Prostatic Hyperplasia. American Urological Association Guidelines. https://www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed2014)
- https://www.vidal.ru/drugs/prostateks-plyus
- https://uroweb.ru/article/hronicheskiy-abakterialniy-prostatit-noviy-podhod-k-ponimaniyu-patogeneza-i-lecheniya
- kr6-dobrokachestvennaya-giperplaziya-predstatelnoj-zhelezy.pdf
- Neymark A.I., Neymark B.A., Nozdrachev N.A., Kondratieva Y.S., Borisen-ko D.V., Arkhipov D.O., Makarova A.A., Oberemok P.A. The use of Afalaza in the treatment of patients with chronic pelvic pain syndrome. Urology 2018;1:106–111. Russian (Неймарк А.И., Неймарк Б.А., Ноздрачев Н.А., Кондратьева Ю.С., Борисенко Д.В., Архипов Д.О., Макарова А.А., Оберемок П.А. Применение препарата Афалаза в лечении больных с синдромом хронической тазовой боли. Урология 2018;1:106–111).
Supplementary files
![](/img/style/loading.gif)